INM logo

InMed Pharmaceuticals (INM) Operating Expenses

Annual Operating Expenses

$9.24 M
-$546.50 K-5.59%

June 30, 2024

Summary

Performance

1-Year Change

-5.59%

3-Year Change

-7.07%

5-Year Change

-11.14%

15-Year Change

+168.49%

INM Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.84%
INM annual total operating expenses is higher than 8.84% of companies in Healthcare sector

High & Low

All-time High

$14.34 M
INM annual total operating expenses is currently -35.58% below its historical high of $14.34 million

3-Year Low

$9.24 M
INM annual total operating expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
INM previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
INM next annual earnings announcement has not yet been scheduled

OtherINMexpensesmetrics:

Annual Total Expenses

$12.73 M
INM annual total expenses is $12.73 million

Annual Interest Expense

-
INM annual interest expense value is unknown

Annual Income Tax

$7100.00
INM annual income tax is $7100.00

Annual Cost Of Goods Sold

$3.50 M
INM annual cost of goods sold is $3.50 million

Quarterly Operating Expenses

$2.25 M
-$227.40 K-9.19%

September 30, 2024

Summary

Performance

3-Month Change

-9.19%

1-Year Change

+7.77%

3-Year Change

-31.83%

5-Year Change

+16.2%

INM Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.83%
INM quarterly total operating expenses is higher than 9.83% of companies in Healthcare sector

High & Low

All-time High

$4.42 M
INM quarterly total operating expenses is currently -49.19% below its historical high of $4.42 million

3-Year Low

$2.03 M
INM quarterly total operating expenses is currently +10.78% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
INM next earnings announcement is scheduled for Feb 13, 2025

OtherINMexpensesmetrics:

Quarterly Total Expenses

$3.02 M
INM quarterly total expenses is $3.02 million

Quarterly Interest Expense

-
INM quarterly interest expense value is unknown

Quarterly Income Tax

$0.00
INM quarterly income tax is $0.00

Quarterly Cost Of Goods Sold

$771.20 K
INM quarterly cost of goods sold is $771.20 thousand

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$9.24 M
INM annual total operating expenses is $9.24 million

Annual SGA

$5.25 M
INM annual SGA is $5.25 million

Annual D&A

$604.50 K
INM annual depreciation & amortization is $604.50 thousand

INM Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.6%+7.8%
3 y3 years-7.1%-31.8%
5 y5 years-11.1%+16.2%

INM Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-35.6%at low-49.2%+10.8%
5 y5-year-35.6%+0.9%-49.2%+44.1%
alltimeall time-35.6%>+9999.0%-49.2%+128.2%

InMed Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$2.25 M(-9.2%)
Jun 2024
$9.24 M(-5.6%)
$2.48 M(+18.7%)
Mar 2024
-
$2.09 M(+2.8%)
Dec 2023
-
$2.03 M(-23.3%)
Sep 2023
-
$2.65 M(+26.8%)
Jun 2023
$9.78 M(-31.8%)
$2.09 M(-10.9%)
Mar 2023
-
$2.34 M(-1.0%)
Dec 2022
-
$2.37 M(-20.8%)
Sep 2022
-
$2.99 M(-9.4%)
Jun 2022
$14.34 M(+44.2%)
$3.30 M(-11.4%)
Mar 2022
-
$3.72 M(-15.9%)
Dec 2021
-
$4.42 M(+52.9%)
Sep 2021
-
$2.89 M(-12.5%)
Jun 2021
$9.94 M(+8.6%)
$3.31 M(+5.5%)
Mar 2021
-
$3.13 M(+62.0%)
Dec 2020
-
$1.93 M(+23.7%)
Sep 2020
-
$1.56 M(+0.2%)
Jun 2020
$9.15 M(-12.0%)
$1.56 M(-29.2%)
Mar 2020
-
$2.20 M(-12.1%)
Dec 2019
-
$2.51 M(-12.9%)
Sep 2019
-
$2.88 M(-15.2%)
Jun 2019
$10.39 M(+58.8%)
$3.39 M(+28.5%)
Mar 2019
-
$2.64 M(+23.1%)
Dec 2018
-
$2.15 M(-4.2%)
Sep 2018
-
$2.24 M(-1.3%)
Jun 2018
$6.55 M(+90.3%)
$2.27 M(+35.9%)
Mar 2018
-
$1.67 M(+35.9%)
Dec 2017
-
$1.23 M(-16.0%)
Sep 2017
-
$1.46 M(-1.8%)
Jun 2017
$3.44 M(+87.2%)
$1.49 M(+60.3%)
Mar 2017
-
$929.40 K(+32.9%)
Dec 2016
-
$699.40 K(+118.7%)
Sep 2016
-
$319.80 K(-19.3%)
Jun 2016
$1.84 M(-46.8%)
$396.10 K(+35.0%)
Mar 2016
-
$293.40 K(-47.4%)
Dec 2015
-
$558.30 K(+8.1%)
Sep 2015
-
$516.50 K(-57.5%)
Jun 2015
$3.46 M(+200.2%)
$1.21 M(-5.0%)
Mar 2015
-
$1.28 M(+161.1%)
Dec 2014
-
$489.70 K(-16.2%)
Sep 2014
-
$584.50 K(-42.4%)
Jun 2014
$1.15 M(+2365.3%)
$1.01 M(+999.5%)
Mar 2014
-
$92.30 K(+162.2%)
Dec 2013
-
$35.20 K(+220.0%)
Sep 2013
-
$11.00 K(-51.8%)
Jun 2013
$46.70 K
$22.80 K(+200.0%)
Mar 2013
-
$7600.00(-226.7%)
DateAnnualQuarterly
Dec 2012
-
-$6000.00(-126.2%)
Sep 2012
-
$22.90 K(-70.1%)
Jun 2012
$168.60 K(-60.1%)
$76.60 K(+237.4%)
Mar 2012
-
$22.70 K(-13.7%)
Dec 2011
-
$26.30 K(-35.5%)
Sep 2011
-
$40.80 K(-60.3%)
Jun 2011
$422.50 K(-12.4%)
$102.90 K(-56.4%)
Mar 2011
-
$236.20 K(+541.8%)
Dec 2010
-
$36.80 K(-14.2%)
Sep 2010
-
$42.90 K(-78.8%)
Jun 2010
$482.10 K(-42.4%)
$202.40 K(+121.7%)
Mar 2010
-
$91.30 K(+4.0%)
Dec 2009
-
$87.80 K(-6.4%)
Sep 2009
-
$93.80 K(-19.8%)
Jun 2009
$836.50 K(-43.8%)
$116.90 K(+17.7%)
Mar 2009
-
$99.30 K(-61.3%)
Dec 2008
-
$256.80 K(-41.4%)
Sep 2008
-
$438.00 K(-34.3%)
Jun 2008
$1.49 M(-9.8%)
$666.90 K(+172.0%)
Mar 2008
-
$245.20 K(-54.2%)
Dec 2007
-
$535.40 K(+22.7%)
Sep 2007
-
$436.40 K(-105.5%)
Jun 2007
$1.65 M(-34.5%)
-$7.98 M(-2933.3%)
Mar 2007
-
$281.80 K(-16.0%)
Dec 2006
-
$335.50 K(-20.0%)
Sep 2006
-
$419.40 K(-23.8%)
Jun 2006
$2.52 M(-16.9%)
$550.40 K(-1.9%)
Mar 2006
-
$561.30 K(-23.9%)
Dec 2005
-
$737.80 K(+13.3%)
Sep 2005
-
$651.00 K(-14.9%)
Jun 2005
$3.03 M(+42.0%)
$764.90 K(+20.9%)
Mar 2005
-
$632.90 K(-13.5%)
Dec 2004
-
$731.60 K(-17.3%)
Sep 2004
-
$885.00 K(0.0%)
Jul 2004
$2.13 M(+55.1%)
$885.00 K(+136.1%)
Apr 2004
-
$374.90 K(-19.4%)
Jan 2004
-
$465.10 K(+1.9%)
Oct 2003
-
$456.40 K(-9.0%)
Jul 2003
$1.38 M(-49.9%)
$501.50 K(+114.0%)
Apr 2003
-
$234.30 K(-14.1%)
Jan 2003
-
$272.80 K(-15.5%)
Oct 2002
-
$322.70 K(-42.9%)
Jul 2002
$2.75 M(-35.1%)
$565.40 K(-17.4%)
Apr 2002
-
$684.20 K(-6.2%)
Jan 2002
-
$729.70 K(-3.0%)
Oct 2001
-
$752.60 K
Jul 2001
$4.24 M
-

FAQ

  • What is InMed Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual operating expenses year-on-year change?
  • What is InMed Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly operating expenses year-on-year change?

What is InMed Pharmaceuticals annual total operating expenses?

The current annual operating expenses of INM is $9.24 M

What is the all time high annual operating expenses for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual total operating expenses is $14.34 M

What is InMed Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, INM annual total operating expenses has changed by -$546.50 K (-5.59%)

What is InMed Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of INM is $2.25 M

What is the all time high quarterly operating expenses for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly total operating expenses is $4.42 M

What is InMed Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, INM quarterly total operating expenses has changed by +$162.10 K (+7.77%)